HAEMATO AG (XTER:HAEK) Marketable Securities : €12.1 Mil (As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. HAEMATO AG's Marketable Securities for the quarter that ended in Jun. 2023 was €12.1 Mil.

HAEMATO AG's annual Marketable Securities increased from Dec. 2020 (€2.8 Mil) to Dec. 2021 (€6.1 Mil) but then declined from Dec. 2021 (€6.1 Mil) to Dec. 2022 (€3.7 Mil).

HAEMATO AG Marketable Securities Historical Data

The historical data trend for HAEMATO AG's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Marketable Securities Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Marketable Securities

Get a 7-Day Free Trial

2.89

2.76

2.75

6.13

3.70

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Marketable Securities	Get a 7-Day Free Trial															3.65	6.13	13.80	3.70	12.14

HAEMATO AG Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

HAEMATO AG (XTER:HAEK) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

HAEMATO AG Marketable Securities Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

HAEK:Germany HAEK:Germany HAEK:Germany

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines